AppLovin delivered its Q2 results on August 5 and the market delivered a swift verdict: the stock fell 20% the next day, extending a brutal month that has now wiped out 34% of its value to leave shares at $346.80.
The post-earnings wreckage is the week's dominant story — but what makes it analytically interesting is the gap between that price action and how the rest of the data is behaving. Options traders turned notably bullish into Friday's session. The put/call ratio dropped to 0.74, nearly three standard deviations below its 20-day average of 0.83 — the lowest defensive reading of the past year. That is the opposite of a market bracing for further pain. Call demand has picked up sharply even as the stock sits at post-crash levels, suggesting a cohort of buyers is using the dip as an entry point rather than a reason to hedge.
The borrow market tells the same unbothered story. Availability has actually loosened dramatically since the earnings drop, now running at 4,023% — roughly 40 shares available to borrow for every one already shorted — up from around 2,625% the week prior and well above the 52-week floor of 573%. Cost to borrow ticked up 25% on the week but remains negligible at 0.47%. Short interest itself edged down about 4% over the past week to 3.9% of the free float, continuing a steady retreat from the 4.6% peak seen in mid-July. There is no short squeeze setup here, and no meaningful rush to build new bearish positions on the wreckage. Positioning looks loose rather than charged.
The Street absorbed the print with a wave of target cuts, though almost no one pulled their Buy or Outperform ratings. Morgan Stanley lowered its target from $720 to $650 while holding Overweight. Goldman Sachs — rated Neutral throughout — trimmed from $585 to $465, the only major firm that had been positioned for this outcome. UBS cut modestly from $798 to $790. The lone downgrade came from Piper Sandler, which moved to Neutral with a $385 target, still above the current price. The consensus mean target of $569.50 implies roughly 64% upside from $346.80 — a gap so wide it reflects genuine disagreement about whether the Q2 miss is structural or a temporary stumble in the e-commerce ramp. Bulls point to AXON's ad-optimization lead, the 51% Q1 revenue growth benchmark, and early signs of Axon Pixel traction among brands. Bears see a gaming-dependent business with an opaque ad engine, a nascent e-commerce segment that has yet to prove its margin profile, and a valuation that even after the crash — PE near 17x, EV/EBITDA around 14x — still prices in a recovery that isn't yet visible in the numbers.
Among peers, the contrast this week was sharp. PubMatic surged 41% and Magnite gained 28% over the same period — both likely benefiting from programmatic ad budget re-allocation as buyers weigh APP's wobble. The Trade Desk was the other major loser, down 24% on the week after its own results disappointed, suggesting the sector's premium names are being held to a higher standard than the mid-tier players right now.
Capital Research added over 3.7 million shares in the most recent reporting period — the largest institutional build in the top-holder list — while Vanguard and Fidelity both reported fresh or expanded positions. CEO Adam Foroughi holds 10.9% of shares outstanding and has not been a recent seller; the insider activity on record is limited to a director's modest July sales at prices well above current levels, which adds no meaningful signal to the post-crash setup.
The next scheduled earnings event is November 4. Between now and then, the question the data will be answering is whether the e-commerce revenue trajectory — the primary bull case — shows up in any interim disclosures or partner commentary, or whether the quiet in the borrow market and the call-side options activity turn out to have been premature.
See the live data behind this article on ORTEX.
Open APP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
